Methyl 4-morpholinobenzoate

Catalog No. :
ACHNLQ845
CAS No. :
23676-05-3
Molecular Formula :
C12H15NO3
Molecular Weight :
221.26

IUPAC Name:methyl 4-morpholinobenzoate

Methyl 4-morpholinobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$115.00Login to see priceIn stockInquiry
25g98%$558.00Login to see priceIn stockInquiry
100g98%$1840.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-morpholinobenzoate
IUPAC Namemethyl 4-morpholinobenzoate
MDL No.MFCD03012127
Molecular FormulaC12H15NO3
Molecular Weight221.26
SMILESO=C(OC)C1=CC=C(N2CCOCC2)C=C1
InChI KeyMMSNLLYQDUZFFR-UHFFFAOYSA-N
SynonymRARECHEM AL BF 1130;METHYL 4-MORPHOLINOBENZENECARBOXYLATE;4-(N-MORPHOLINO)-BENZENE METHYLCARBOXYLATE;Methyl 4-morpholin-4-yl-benzoate;methyl 4-morpholinobenzoate;4-morpholinobenzoic acid methyl ester;4-(4-morpholinyl)Benzoic acid Methyl ester;Benzoic acid, 4-(4-morpholinyl)-, methyl ester
CAS No.23676-05-3
PubChem CID5178200

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHNLQ845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACEFXM458 route compound structure diagram
    ACEFXM4587470-38-4 In Stock
  4. Then
  5. ACHNLQ845 route product structure diagram
    ACHNLQ84523676-05-3 In Stock
Inquiry

2. ACHNLQ845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDSAM359 route compound structure diagram
    ACDSAM359619-42-1 In Stock
  4. Then
  5. ACHNLQ845 route product structure diagram
    ACHNLQ84523676-05-3 In Stock
Inquiry

Comments (0)